UroGen Pharma's IPO

UroGen Pharma raised a round of funding on May 04, 2017. Investors include Public.

UroGen Pharma (NASDAQ: URGN), fka Theracoat, is a clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies with…

Articles about UroGen Pharma's IPO: